These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26727639)

  • 1. A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group.
    Miller TP; Getz KD; Kavcic M; Li Y; Huang YS; Sung L; Alonzo TA; Gerbing R; Daves M; Horton TM; Pulsipher MA; Pollard J; Bagatell R; Seif AE; Fisher BT; Gamis AS; Aplenc R
    Leuk Lymphoma; 2016 Jul; 57(7):1567-74. PubMed ID: 26727639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia.
    Getz KD; Miller TP; Seif AE; Li Y; Huang YS; Bagatell R; Fisher BT; Aplenc R
    Cancer Med; 2015 Sep; 4(9):1356-64. PubMed ID: 26105201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
    Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
    JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
    Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
    Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early discharge as a mediator of greater ICU-level care requirements in patients not enrolled on the AAML0531 clinical trial: a Children's Oncology Group report.
    Getz KD; Miller TP; Seif AE; Li Y; Huang YS; Alonzo T; Gerbing R; Sung L; Hall M; Bagatell R; Gamis A; Fisher BT; Aplenc R
    Cancer Med; 2016 Sep; 5(9):2412-6. PubMed ID: 27474232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.
    Sung L; Aplenc R; Alonzo TA; Gerbing RB; Wang YC; Meshinchi S; Gamis AS
    Int J Cancer; 2016 Nov; 139(9):1930-5. PubMed ID: 27312107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004.
    Bochennek K; Hassler A; Perner C; Gilfert J; Schöning S; Klingebiel T; Reinhardt D; Creutzig U; Lehrnbecher T
    Blood Cancer J; 2016 Jan; 6(1):e382. PubMed ID: 26771808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine.
    Johannsen KH; Handrup MM; Lausen B; Schrøder H; Hasle H
    Pediatr Blood Cancer; 2013 Jul; 60(7):1154-60. PubMed ID: 23281248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes of pediatrics acute myeloid leukemia (AML) and associated factors in the country's tertiary referral hospital, Ethiopia.
    Mamo W; Moges A; Yesuf SA; Mohamedsaid A; Arega G
    BMC Cancer; 2024 May; 24(1):640. PubMed ID: 38789952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in overweight and underweight children with acute myeloid leukemia.
    Lange BJ; Gerbing RB; Feusner J; Skolnik J; Sacks N; Smith FO; Alonzo TA
    JAMA; 2005 Jan; 293(2):203-11. PubMed ID: 15644547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient supportive care following chemotherapy for acute myeloblastic leukemia.
    Allan DS; Buckstein R; Imrie KR
    Leuk Lymphoma; 2001 Jul; 42(3):339-46. PubMed ID: 11699398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's cancer group study CCG-2891.
    Gamis AS; Howells WB; DeSwarte-Wallace J; Feusner JH; Buckley JD; Woods WG
    J Clin Oncol; 2000 May; 18(9):1845-55. PubMed ID: 10784625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group.
    Miller TP; Troxel AB; Li Y; Huang YS; Alonzo TA; Gerbing RB; Hall M; Torp K; Fisher BT; Bagatell R; Seif AE; Sung L; Gamis A; Rubin D; Luger S; Aplenc R
    Pediatr Blood Cancer; 2015 Jul; 62(7):1184-9. PubMed ID: 25760019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group.
    Getz KD; Li Y; Alonzo TA; Hall M; Gerbing RB; Sung L; Huang YS; Arnold S; Seif AE; Miller TP; Bagatell R; Fisher BT; Adamson PC; Gamis A; Keren R; Aplenc R
    Pediatr Blood Cancer; 2015 Oct; 62(10):1775-81. PubMed ID: 25946708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.
    Alexander TB; Wang L; Inaba H; Triplett BM; Pounds S; Ribeiro RC; Pui CH; Rubnitz JE
    Cancer; 2017 Oct; 123(19):3791-3798. PubMed ID: 28556917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
    J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia.
    Getz KD; Szymczak JE; Li Y; Madding R; Huang YV; Aftandilian C; Arnold SD; Bona KO; Caywood E; Collier AB; Gramatges MM; Henry M; Lotterman C; Maloney K; Mian A; Mody R; Morgan E; Raetz EA; Rubnitz J; Verma A; Winick N; Wilkes JJ; Yu JC; Fisher BT; Aplenc R
    JAMA Netw Open; 2021 Oct; 4(10):e2128385. PubMed ID: 34709389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer Registry.
    Foresto SA; Youlden DR; Baade PD; Hallahan AR; Aitken JF; Moore AS
    Pediatr Blood Cancer; 2015 Sep; 62(9):1664-6. PubMed ID: 25855531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes among pediatric patients with cancer who are treated on trial versus off trial: A matched cohort study.
    Schapira MM; Stevens EM; Sharpe JE; Hochman L; Reiter JG; Calhoun SR; Shah SA; Bailey LC; Bagatell R; Silber JH; Tai E; Barakat LP
    Cancer; 2020 Aug; 126(15):3471-3482. PubMed ID: 32453441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient supportive care for pediatric acute myeloid leukemia: a single institution's experience.
    Potashner R; Weinblatt ME; Glasser CL
    Pediatr Hematol Oncol; 2021 Nov; 38(8):722-730. PubMed ID: 33792501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.